Personas / Equipo Humano

Belen Arranz Martí

Buscador de publicaciones

Publicaciones

  • Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.

    Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.

    Early Intervention in Psychiatry . 13(3): 414-424. Nº de citas: 17

    [doi:10.1111/eip.12498]

  • Arranz B, Sanchez-Autet M, San L, Safont G, Fuente-Tomás L, Hernandez C, Jose Luis Bogas Galisteo and García-Portilla MP.

    Are plasma 25-hydroxyvitamin D and retinol levels and one-carbon metabolism related to metabolic syndrome in patients with a severe mental disorder?

    PSYCHIATRY RESEARCH . 273: 22-29. Nº de citas: 4

    [doi:10.1016/j.psychres.2019.01.005]

  • Fuente-Tomas L, Arranz B, Safont G, Sierra P, Sanchez-Autet M, Garcia-Blanco A and Garcia-Portilla MP.

    Classification of patients with bipolar disorder using k-means clustering.

    PLoS One . 14(1): . Nº de citas: 30

    [doi:10.1371/journal.pone.0210314]

  • De la Fuente-Tomás L, Sierra P, Sanchez-Autet M, García-Blanco A, Safont G, Arranz B and García-Portilla MP.

    Sleep disturbances, functioning, and quality of life in euthymic patients with bipolar disorder.

    PSYCHIATRY RESEARCH . 269: 501-507. Nº de citas: 29

    [doi:10.1016/j.psychres.2018.08.104]

  • Sánchez Autet M, Garriga M, Zamora FJ, González I, Usall J, Tolosa L, Benítez C, Puertas R and Arranz B.

    Screening of alcohol use disorders in psychiatric outpatients: influence of gender, age, and psychiatric diagnosis.

    Adicciones . 30(4): 251-263. Nº de citas: 7

    [doi:10.20882/adicciones.885]

  • Costa J, García-Blanco A, Cañada Y, García-Portilla MP, Safont G, Arranz B, Sanchez-Autet M, Livianos L, Fornés-Ferrer V and Sierra P.

    Are affective temperaments determinants of quality of life in euthymic patients with bipolar disorder?

    JOURNAL OF AFFECTIVE DISORDERS . 230: 101-107. Nº de citas: 9

    [doi:10.1016/j.jad.2018.01.007]

  • Sanchez-Autet M, Arranz B, Safont G, Sierra P, Garcia-Blanco A, de la Fuente L, Garriga M and García-Portilla MP.

    Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.

    JOURNAL OF AFFECTIVE DISORDERS . 229: 95-104. Nº de citas: 33

    [doi:10.1016/j.jad.2017.12.038]

  • Arranz B, Garriga M, García-Rizo C and San L.

    Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 28(2): 227-242. Nº de citas: 25

    [doi:10.1016/j.euroneuro.2017.12.006]

  • Butjosa A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.

    Development and validation of the Questionnaire of Stressful Life Events (QSLE).

    JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Nº de citas: 14

    [doi:10.1016/j.jpsychires.2017.08.016]

  • Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J and Vieta E.

    Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(10): 959-969. Nº de citas: 15

    [doi:10.1016/j.euroneuro.2017.08.429]